What this means
This trial is still recruiting people, so no results are available yet. It will compare three groups, and it does not yet show whether the treatment works.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 60 and over
- Where
- 1 site
The science
- Registered title
- Efficacy of CBT-I With Adjuvant Melatonin in Older Adults Chronic Insomnia
- Trial ID
- NCT07695246 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Insomnia, Aging, Sleep Disorders
- What is tested
- Cognitive behavioural therapy for insomnia, Melatonin 3 mg immediate-release, Psychoeducation, Placebo Oral Tablet
- Sponsor
- The University of Hong Kong
- Ages
- 60 Years to no maximum
- Dates
- First posted Jul 10, 2026 · updated Aug 21, 2026
Registry summary
This study tests the efficacy of cognitive behavioural therapy for insomnia (CBT-I) with or without adjunct melatonin in older adults with insomnia. Adults aged 60 or above with chronic insomnia will be randomly assigned to one of three groups: (1) CBT-I plus nightly melatonin, (2) CBT-I plus nightly placebo tablet, or (3) sleep health psychoeducation plus nightly placebo tablet. All group sessions occur weekly for four weeks.
Sites (1)
- Sleep Research Clinic and Laboratory, Department of Psychology, The University of Hong Kong, Hong Kong, Hong Kong
